510(k) Report

FDA product code · Orthopedic

Filler, Recombinant Human Bone Morphogenetic Protein, Collagen Scaffold With Metal Prosthesis, Osteoinduction

NEKClass IIIPMA required1 decision since 20021 recall

1 FDA decision since 2002. 1 recall names this code; it is not Class I.

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026 Download the data (CSV)

FIG. A — Illustration, orthopedic panel

Twenty years of NEK at a glance: how often FDA decides these devices, how long 510(k) reviews take, how often they are recalled, and how many adverse event reports name the code.

FDA decisions per year · NEK

1in 2025

2007: 52008: 52009: 32010: 42011: 42012: 62013: 62014: 12015: 42016: 32017: 52018: 22019: 62020: 42021: 32022: 42023: 42024: 12025: 12026 (partial year): 5
2007high 6 (2012) · low 1 (2014)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · NEK

Too few NEK 510(k)s in any year since 2007 to give a median.

Recalls per year · NEK

1in 2018

2018: 1
2007high 1 (2018) · low 0 (2007)2026

Class I (0 since 2007) Class II/III not classified

Adverse event reports per year · NEK

49in 2025

2007: 682008: 872009: 2322010: 3052011: 3142012: 1,9572013: 3,4972014: 1,9282015: 1,7342016: 1,5282017: 7992018: 1792019: 372020: 312021: 232022: 82023: 142024: 362025: 49
2007high 3,497 (2013) · low 8 (2022)2025

MAUDE reports naming product code NEK, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
20075—068
20085—087
20093—0232
20104—0305
20114—0314
20126—01,957
20136—03,497
20141—01,928
20154—01,734
20163—01,528
20175—0799
20182—1179
20196—037
20204—031
20213—023
20224—08
20234—014
20241—036
20251—049
20265—0—
FIG. 1 — NEK by year, 2007–2026Sources: FDA decision databases, recall and enforcement reports, MAUDE · Data through Oct 25, 2026

Planning a device in NEK? A 510(k) Report ranks candidate predicates in this code by lineage, citations and recall history, with the review-time outlook.

See the 510(k) Report